/ Published in 2009, Publication

Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania

Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania.

Watson-Jones D, Baisley K, Rusizoka M, Mugeye K, Weiss H, Changalucha J, Clayton T, Hambleton I, Ross DA, Hayes R.
Contemporary Clinical Trials. 2009; 30: 504-512.
PMID: 19665587
Related citation

What you can read next

A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial.
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results
Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission.